2022
DOI: 10.1007/s00403-022-02416-1
|View full text |Cite
|
Sign up to set email alerts
|

Oral vitamin D modulates the epidermal expression of the vitamin D receptor and cathelicidin in children with atopic dermatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 53 publications
0
10
0
Order By: Relevance
“…21 Oral vitamin D3 supplementation in children with atopic eczema reduces AD severity through increasing the epidermal expression of the vitamin D receptor and cathelicidin in lesional skin. 22 NICE and RCPCH recommend treatment of vitamin D deficiency in children for 8-12 weeks (colecalciferol 3000IU daily aged 1-5 months, 6000IU daily aged 6months-11 years, 10,000IU daily aged 12-17 years), while they recommend supplementation of vitamin D (colecalciferol 400-600IU daily) for children with vitamin D insufficiency. 23 The presence of FLG LOFM has been linked to higher vitamin D levels, with the suggestion that the presence of these variants favours intracutaneous vitamin D3 production in people with Northern European ancestry.…”
Section: Discussionmentioning
confidence: 99%
“…21 Oral vitamin D3 supplementation in children with atopic eczema reduces AD severity through increasing the epidermal expression of the vitamin D receptor and cathelicidin in lesional skin. 22 NICE and RCPCH recommend treatment of vitamin D deficiency in children for 8-12 weeks (colecalciferol 3000IU daily aged 1-5 months, 6000IU daily aged 6months-11 years, 10,000IU daily aged 12-17 years), while they recommend supplementation of vitamin D (colecalciferol 400-600IU daily) for children with vitamin D insufficiency. 23 The presence of FLG LOFM has been linked to higher vitamin D levels, with the suggestion that the presence of these variants favours intracutaneous vitamin D3 production in people with Northern European ancestry.…”
Section: Discussionmentioning
confidence: 99%
“…Three separate studies demonstrated that prebiotic supplementation has effective long-term protective effects on AD and were associated with a reduction in plasma levels of total IgE [112] and a lowered risk of AD [113]. For vitamin supplementation, vitamin D3 (n = 12) [70][71][72][73][74][75][76][77][78][79][80] was exclusively studied in the pediatric population, while investigations on dietary fats (n = 4) explored γ-linolenic acid [81,82], docosahexaenoic acid [83,84], and arachidonic acid [83]. Studies on diet-related approaches (n = 5) involved avoidance of monosodium glutamate [118], eggs [120,122] and/or cow's milk [120], supplementation with whey or casein [121], and selected foods consumption [119].…”
Section: Pediatric Populationmentioning
confidence: 99%
“…A randomised trial showed that patients with septic shock and severe sepsis rapidly induced LL-37 expression after vitamin D supplementation [126]. According to a report, vitamin D supplementation induced LL-37 in children with atopic dermatitis [157]. Furthermore, vitamin D supplementation enhanced the expression of LL-37 and increased the resistance to SARS-CoV-2 viral infection in COVID-19 patients [122].…”
Section: Sepsis and Infectious Diseasesmentioning
confidence: 99%